Developing a patient safety surveillance system to identify adverse events in the intensive care unit.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 20502165.
- Also identified by DOI 10.1097/CCM.0b013e3181dde2d9.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Aggregation of adverse drug event data has evolved in the last decade. Several approaches are available to augment the standard voluntary incident reporting system. Most of these methods are applicable to nonmedication adverse events as well. To identify appropriately system trends as well as process failures, intensive care units should participate in various collection methods. Several different methods are available for robust adverse drug event data collection, such as target chart review, nontargeted chart review, and direct observation. As the various methods usually capture different types of events, employing more than one technique will improve the assessment of intensive care unit care. Some of these surveillance methods offer real-time or near real-time identification of adverse drug events and potentially afford the practitioner time for intervention. Continued development of adverse drug event detection will allow for further quality improvement efforts and preventive strategies to be utilized.
Medical subject headings
- Health Care Surveys
- Intensive Care Units
- Medication Errors
- Safety Management